Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: Trends over time

American Heart Journal

Volumn 153, Issue 6, 2007, Pages 970-978

  Champney, Kimberly P ^a   Veledar, Emir ^a   Klein, Mitchel ^b   Samady, Habib ^a   Anderson, Deborah ^a   Parashar, Susmita ^a   Wenger, Nanette ^a   Vaccarino, Viola ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HAZARD RATIO; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; FEMALE; GEORGIA; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEX DISTRIBUTION; SEX FACTORS; STENTS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 34249668405     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.03.036     Document Type: Article

References (42)

1. McGovern P.G., Pankow J.S., Shahar E., et al. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. NEng J Med (1996) 884-890
2. Centers for Disease Control and Prevention. Trends in Ischemic Heart Disease Deaths-United States 1990-1994. JAMA 277 (1997) 1109
3. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 335 (2000) 688-700
4. McGovern PG, Jacobs Jr DR, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. 2001:19-24. [2001 Jul 3].
5. Fox K., Mehta S., Peters R., et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 110 (2004) 1202-1208
6. Unal B., Critchley J.A., and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109 (2004) 1101-1107
7. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv 67 (2006) 87-112
8. Lansky A.J., Hochman J.S., Ward P.A., et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. Circulation 111 (2005) 940-953
9. Zhang Z., Weintraub W.S., Mahoney E.M., et al. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial). Am J Cardiol 93 (2004) 404-409
10. Jacobs A.K., Johnston J.M., Haviland A., et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. J Am Coll Cardiol 39 (2002) 1608-1614
11. Iakovou I., Dangas G., Mehran R., et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 15 (2003) 18-22
12. Fernandes L.S., Tcheng J.E., O'Shea J.C., et al. Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study. J Am Coll Cardiol 40 (2002) 1085-1091
13. Razakjr O.A., Tan H.C., Yip W.L., et al. Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention. J Interv Cardiol 18 (2005) 33-37
14. Farouque H.M., Tremmel J.A., Raissi Shabari F., et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 45 (2005) 363-368
15. Peterson E.D., Lansky A.J., Kramer J., et al. National Cardiovascular Network I. Clinical effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 88 (2001) 359-364
16. Thompson C.A., Kaplan A.V., Friedman B.J., et al. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era. Catheter Cardiovasc Interv 67 (2006) 25-31
17. Franklin K., Goldberg R.J., Spencer F., et al. Implications of diabetes in patients with acute coronary syndromes. The global registry of acute coronary events. Arch Intern Med 164 (2004) 1457-1463
18. Lee W.L., Cheung A.M., Cape D., et al. Impact of diabetes on coronary artery disease in women and men. A meta-analysis of prospective studies. Diabetes Care 23 (2000) 962-968
19. Juutilainen A., Kortelainen S., Lehto S., et al. Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27 (2004) 2898-2904
20. Natarajan S., Liao Y., Cao G., et al. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163 (2003) 1735-1740
21. Gustafsson I., Brendorp B., Seibaek M., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43 (2004) 771-777
22. Goldstein L.B., Adams R., Becker K., et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32 (2001) 280-299
23. Cole J.H., Miller III J.I., Sperling L.S., et al. Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol 41 (2003) 521-528
24. Weintraub W.S., Clements Jr. S.D., Crisco L.V., et al. Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University. Circulation 107 (2003) 1271-1277
25. Loutfi M., Mulvihill N.T., Boccalatte M., et al. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients. Catheter Cardiovasc Interv 58 (2003) 451-454
26. Rich-Edwards J.W., Manson J.E., Hennekens C.H., et al. The primary prevention of coronary heart disease in women. N Engl J Med 332 (1995) 1758-1766
27. Crowley A., Menon V., Lessard D., et al. Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study). Am Heart J 146 (2003) 824-831
28. Graham M.M., Ghali W.A., Faris P.D., et al. Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography. Diabetes Care 26 (2003) 3142-3147
29. Boccuzzi G., Belli G., Pagnotta P., et al. Evidence for a "gender paradox" in diabetic patients undergoing percutaneous coronary intervention: adverse preprocedural risk but favorable long-term clinical outcome in women. Ital Heart J 6 (2005) 962-967
30. Kanaya A.M., Grady D., and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162 (2002) 1737-1745
31. Smith S.C.J.M.D.C., Faxon D.M.D.C., Cascio W.M.D., et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients. Circulation 105 (2002) e165-e169
32. Flaherty J.D.M.D., and Davidson C.J.M.D. Diabetes and coronary revascularization. [Review]. JAMA 293 (2005) 1501-1508
33. Radke P.W., Friese K., Buhr A., et al. Comparison of coronary restenosis rates in matched patients with versus without diabetes mellitus. Am J Cardiol 98 (2006) 1218-1222
34. Abizaid A., Kornowski R., Mintz G.S., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
35. Carrozza J., Duntz R., Fishman R., et al. Restenosis after arterial injury caused by coronary stenting in patients with coronary artery disease. J Am Coll Cardiol 32 (1993) 584-589
36. Baron A.D. Hemodynamic actions of insulin. Am J Physiol 297 (1994) E187-E202
37. Sobel B.E. Potentiation of vasculopathy by insulin: implications from an NHLBI clinical alert. Circulation 93 (1996) 1613-1615
38. Gu K., Cowie C.C., and Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 281 (1999) 1291-1297
39. Anonymous. Management of dyslipidemia in adults with diabetes. Am Diabetes Assoc 21 (1998) 179-182
40. Anonymous. American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 20 Suppl 1 (1997) S1-S70
41. Aronow W.S., and Ahn C. Association of diabetes mellitus using old and new diagnostic criteria with incidence of new coronary events in older men and women. Am J Cardiol 85 (2000) 104-105
42. Abraira C., Colwell J., Nuttall F., et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans affairs cooperative study on glycemic control and complications in type II diabetes. Arch Intern Med 157 (1997) 181-188